|
|
|||||||
 |
|
|
LinkBack | Thread Tools | Display Modes |
08-13-2010, 03:59 AM
|
|||
|
|||
Aeterna Zentaris Reports Second Quarter 2010 Financial and Operating Results
All amounts are in U.S. dollars QUEBEC CITY, Aug. 12 /PRNewswire-FirstCall/ - Aeterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ) ("the Company"), a late-stage drug development company specialized in oncology and endocrinology, today reported financial and operating results for the second quarter ended June 30, 2010 . Second Quarter 2010 Highlights Pipeline development Perifosine - April 5, 2010 ...
    
|
|
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Rosetta Genomics Reports Second Quarter 2010 Financial Results | cancerfr | Mesothelioma | 0 | 09-09-2010 12:10 AM |
| CEL-SCI Corporation Reports Third Quarter 2010 Financial Results | cancerfr | Adrenocortical Carcinoma | 0 | 08-17-2010 05:47 AM |
| Incyte Reports Second Quarter 2010 Financial Results | cancerfr | Multiple Myeloma/Other Plasma Cell Neoplasms | 0 | 08-05-2010 12:57 PM |
| ZymoGenetics Reports Second Quarter 2010 Financial Results | cancerfr | Melanoma | 0 | 08-04-2010 06:54 AM |
| Æterna Zentaris Reports Fourth Quarter and Full-Year 2009 Financial and Operating Res | cancerfr | Bladder Cancer | 0 | 03-24-2010 03:38 PM |
Linear Mode
